Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
We've identified the following companies as similar to Jacobio Pharmaceuticals Group Co., Ltd. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
| Name | Ticker | Current Portion of LT Debt & Capital Leases |
|---|---|---|
| LakeShore Biopharma Co Ltd | NASDAQCM:LSB | - |
| Shanghai Serum Bio Technology Co | SHSE:688163 | - |
| Staidson Beijing Biopharma | SZSE:300204 | 58.245 K |
| Healthcare | SECTOR:HLTH.CN | 1.164 M |
| Jacobio Pharmaceuticals Group Co., Ltd. | OTCPK:JBPH.F | 9.036 M |
| Shanghai Kehua Bio-Engineering Co Ltd | SZSE:002022 | 57.665 M |
| Mabpharm Ltd | SEHK:2181 | 103.5 M |
| Cutia Therapeutics | SEHK:2487 | 240.1 M |
| Shanghai Junshi Biosciences Co Ltd | SEHK:1877 | 262.6 M |
| Ascentage Pharma Grp International | SEHK:6855 | 520.4 M |
| Lepu Biopharma Co Ltd | SEHK:2157 | 609.5 M |
| Shanghai Henlius Biotech Inc | SEHK:2696 | 2.724 B |
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Current Portion of LT Debt & Capital Leases in the popular category include:
The portion of long term debt and capital leases which is due in the upcoming year.
Jacobio Pharmaceuticals reported current portion of lt debt & capital leases of 9.036 M for the latest quarter ending December 31, 2024 on its balance sheet.
The tables below summarizes Jacobio Pharmaceuticals’s Current Portion of LT Debt & Capital Leases and common size over the last five years:
| Fiscal Year | Current Portion of LT Debt & Capital Leases | Assets | % Assets |
|---|---|---|---|
| 2020-12-31 | 1.323 M | 286.1 M | 0.5% |
| 2021-12-31 | 773.879 T | 270.9 M | 0.3% |
| 2022-12-31 | 1.904 M | 228.3 M | 0.8% |
| 2023-12-31 | 2.019 M | 205.8 M | 1.0% |
| 2024-12-31 | 9.036 M | 186.2 M | 4.9% |
The tables below summarizes Jacobio Pharmaceuticals’s Current Portion of LT Debt & Capital Leases and common size over the last four quarters:
| Quarter Ending | Current Portion of LT Debt & Capital Leases | Assets | % Assets |
|---|---|---|---|
| 2024-03-31 | 2.036 M | 181.8 M | 1.1% |
| 2024-06-30 | 2.023 M | 180.6 M | 1.1% |
| 2024-09-30 | 9.399 M | 193.7 M | 4.9% |
| 2024-12-31 | 9.036 M | 186.2 M | 4.9% |